Since cardiovascular disorders are often predominant causes of death in patients with pheochromocytoma 7 the hearts of such patients were reviewed in search of myocardial lesions. In addition ...

Cite this: Pheochromocytoma: Recommendations for Clinical Practice from the First International Symposium - Medscape - Feb 01, 2007.

The First International Symposium on Pheochromocytoma, held in October 2005, included discussions about developments concerning these rare catecholamine-producing tumors. Recommendations were made ...

The first description of pheochromocytoma in 1886 has been attributed to Felix Fränkel, who described an 18-year-old woman with bilateral adrenal “sarcoma and angio-sarcoma.” We reviewed the ...

Purpose We examined the value of SDHD mutation screening in patients presenting with apparently sporadic and familial pheochromocytoma for the identification of SDHD-related pheochromocytomas.

These two tumors arise in the adrenal gland (where they are known as a pheochromocytoma) or in the parts of the body that control blood pressure (where they are known as paraganglioma).

This review summarizes the recommendations for testing, localization and treatment of pheochromocytoma, and is based on discussions at the First International Symposium on Pheochromocytoma.

SDHD gene mutations in patients presenting with apparently sporadic adrenal pheochromocytoma are rare. We recommend SDHD mutation screening for patients presenting with a family history of ...